$CORT Cashflow Statement | Understand Stock

$CORT

$86.28 -$1.31 (1.5%) Close

$CORT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation
Accretion of discount on marketable securities, net
Amortization of cloud computing arrangements
Depreciation and amortization
Deferred income taxes
Non-cash amortization of right-of-use asset
Amortization of right-of-use asset
Other
Changes in operating assets and liabilities:
Trade receivables
Insurance recovery receivable related to Melucci litigation (Note 10)
Inventory
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued clinical expenses
Accrued research and development expenses
Accrued and other liabilities
Accrued settlement related to Melucci litigation (Note 10)
Long-term accrued income taxes
Operating lease liability

Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property and equipment
Proceeds from sales of marketable securities
Proceeds from maturities of marketable securities
Purchases of marketable securities
Net cash provided (used in) by investing activities
Cash flows from financing activities:
Proceeds from issuance of common stock under our incentive award plan, net of issuance costs
Proceeds from stock option exercises, net of issuance costs
Proceeds from purchases under the Employee Stock Purchase Program
Total proceeds from issuance of common stock under our incentive award plan, net of issuance costs
Repurchases of common stock in connection with Stock Repurchase Program
Tender Offer
Stock Repurchase Program
Total repurchases of common stock in connection with Stock Repurchase Program
Repurchase of common stock in connection with Tender Offer
Cash paid to satisfy statutory withholding requirement for net settlement of cashless option exercises and vesting of restricted stock grants
Net cash used in financing activities
Net effect of exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents, at beginning of period
Cash and cash equivalents, at end of period
Income taxes paid
Supplemental disclosure:
Income taxes paid
Exercise cost of shares repurchased for net settlement of cashless option exercises
Recognition of right-of-use asset in exchange for lease liability

Comments